Kineta (KA) News Today

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

$0.53

+0.04 (+9.03%)

(As of 01:33 PM ET)

Source

Source	Headline
	Kineta (KA) Price Target Increased by 25.58% to 13.77 msn.com - April 18 at 10:48 AM
	Kineta, Inc.: Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial finanznachrichten.de - April 9 at 7:43 AM
	Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial globenewswire.com - April 8 at 4:01 PM
	Kineta, Inc.: Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update finanznachrichten.de - March 22 at 11:37 AM
	Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update globenewswire.com - March 21 at 4:02 PM
	KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 VISTA-101 Clinical Trial; Initial Clinical Response Data Reported globenewswire.com - March 12 at 8:00 AM
	Kineta CEO laid off as cutbacks leave biotech with 4 employees bizjournals.com - March 1 at 2:23 AM
	Kineta stock falls ~25.7% after co cuts workforce by 64%, including CEO msn.com - February 29 at 4:22 PM
	Kineta Announces Restructuring and Exploration of Strategic Alternatives globenewswire.com - February 29 at 8:30 AM
	Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium finance.yahoo.com - February 22 at 9:47 AM
	Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium globenewswire.com - February 22 at 8:30 AM
	Kineta to Present at Upcoming Investor Conferences finance.yahoo.com - February 14 at 1:31 PM
	Kineta to Present at Upcoming Investor Conferences globenewswire.com - February 14 at 8:30 AM
	Kineta to Participate in H.C. Wainwright Virtual @Home Fireside Chat Series stockhouse.com - February 7 at 9:48 AM
	KA: Phase I/II Update finance.yahoo.com - January 29 at 12:51 PM
	Kineta, Inc.: Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors finanznachrichten.de - January 17 at 10:11 AM
	Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer finance.yahoo.com - December 13 at 12:49 PM
	Kineta to Present at the Life Sciences Investor Forum December 14th finance.yahoo.com - December 12 at 4:47 PM
	Kineta to Host KOL Event to Review New Data from VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors on December 5, 2023 finance.yahoo.com - November 28 at 12:05 PM
	Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit finance.yahoo.com - November 9 at 3:25 PM
	Buy Rating for Kineta Backed by Promising Drug Trials and Solid Financial Performance markets.businessinsider.com - November 8 at 7:05 AM
	KA: Third Quarter Results - MSN msn.com - November 7 at 10:53 PM
	KA: Third Quarter Results finance.yahoo.com - November 7 at 12:52 PM
	Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting benzinga.com - November 6 at 12:38 PM
	Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting finance.yahoo.com - November 6 at 12:38 PM
	Kineta Insider Purchases Yet To Pay Off Regardless Of Recent Strength finance.yahoo.com - November 4 at 1:10 PM
	Kineta, Inc.: Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update finanznachrichten.de - November 4 at 8:09 AM
	Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting benzinga.com - November 3 at 8:14 PM
	Kineta: Q3 Earnings Snapshot chron.com - November 3 at 8:14 PM
	Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting finance.yahoo.com - November 3 at 8:14 PM
	Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update finance.yahoo.com - November 3 at 8:14 PM
	Promising Prospects for Kineta’s VISTA-101 Trial and KVA12123 Monotherapy Drive Buy Rating markets.businessinsider.com - October 18 at 10:23 AM
	Kineta Announces First Patient Dosed in Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors finance.yahoo.com - October 17 at 12:49 PM
	KA: Autumn Activity finance.yahoo.com - October 12 at 1:42 PM
	Kineta Announces KVA12123 and Anti-CD27 Agonist Antibody Abstracts Accepted for Poster Presentations at Society for Immunotherapy of Cancer (SITC) 2023 finance.yahoo.com - October 12 at 1:42 PM
	marketbeat.com - October 12 at 10:20 AM
	Kineta to Present Preclinical Data on VISTA Blocking KVA12123 at Immuno US 2023 finance.yahoo.com - October 9 at 2:59 PM
	Kineta, Inc. Announces Closing of $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules finance.yahoo.com - October 5 at 5:59 PM
	Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules finance.yahoo.com - October 4 at 10:32 AM
	Kineta Presents New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy finance.yahoo.com - October 4 at 10:32 AM
	Kineta Announces Participation at October Investor Conferences finance.yahoo.com - September 28 at 9:52 AM
	Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy finance.yahoo.com - September 25 at 12:40 PM
	Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression finance.yahoo.com - September 18 at 1:54 PM
	Insider Buying: Thierry Guillaudeux Acquires 10,000 Shares of Kineta Inc finance.yahoo.com - September 16 at 10:17 PM
	Kineta to Participate in Upcoming Investor Conferences finance.yahoo.com - August 31 at 9:47 AM
	KA: Second Quarter Results finance.yahoo.com - August 16 at 6:33 PM
	Kineta Second Quarter 2023 Earnings: Beats Expectations finance.yahoo.com - August 15 at 10:05 AM
	Kineta, Inc.: Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update finanznachrichten.de - August 12 at 8:48 AM
	Kineta: Q2 Earnings Snapshot sfgate.com - August 11 at 5:46 PM
	Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update finance.yahoo.com - August 11 at 5:46 PM

Get Kineta News Delivered to You Automatically

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

KA Media Mentions By Week

KA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KA
News Sentiment
▼
0.55

0.52
▲
Average
Medical
News Sentiment

KA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KA Articles
This Week
▼
1

1
▲
KA Articles
Average Week

Get Kineta News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:KA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Kineta (KA) News Today

KA Media Mentions By Week

KA Media Sentiment

KA News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info